Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Use this AYTU page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AYTU quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AYTU SEC filings page. Lician reads the product cache first so this HTML stays unique to Aytu BioScience Inc even when a live quote feed is slow.
Latest cached year on this hub. Full AYTU income, balance, and cash tables.